Banyan Biomarkers Announces Presentation on Discovery and Expected Usefulness of Brain Biomarkers at Boston's CIMIT Symposium.GAINESVILLE, Fla. -- Banyan banyan (băn`yən), species of fig (Ficus bengalensis) of the family Moraceae (mulberry family), native to India, where it is venerated. Its seeds usually germinate in the branches of some tree where they have been dropped by birds. Biomarkers, Inc. announced today that Ronald L. Hayes, Ph.D., Director of Clinical Programs, will present information on the development of a panel of proprietary protein biomarkers in detecting traumatic brain injury Traumatic brain injury (TBI), traumatic injuries to the brain, also called intracranial injury, or simply head injury, occurs when a sudden trauma causes brain damage. TBI can result from a closed head injury or a penetrating head injury and is one of two subsets of acquired brain at the upcoming Traumatic Brain Injury Symposium organized by the Center for Integration of Medicine and Innovative Technology (CIMIT CIMIT Center for Innovative Minimally Invasive Therapy (Massachusetts General Hospital) CIMIT Centro de Investigacion Medica Instituto Traumatologico (Chile) ). The presentation will be held at 8:30 a.m., Thursday, November 15, 2007 at the Schepens Starr Center for Scientific Communications, 2nd floor, 85 Cambridge Street in Boston, Massachusetts “Boston” redirects here. For other uses, see Boston (disambiguation). Boston is the capital and most populous city of Massachusetts.[3] The largest city in New England, Boston is considered the unofficial economic and cultural center of the entire New . Banyan Biomarkers has pre-clinical data from animal models indicating that the Company's biomarkers could be useful diagnostic indicators for brain injury. Banyan Biomarkers is conducting an international clinical trial to demonstrate the effectiveness of their proprietary biomarkers in detecting brain injury. The Company's goal is to receive FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval for the Company's biomarkers to be used as in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. diagnostic blood tests for detecting brain injury. Ronald L. Hayes, Ph.D. is Director of the Banyan Center of Innovative Research and Director, Clinical Programs for Banyan Biomarkers, Inc. located in Alachua, Florida Alachua is a city in Alachua County, Florida, United States. According to 2006 U.S. Census Bureau estimates, the city's population was 7,554.[2] The city is part of the Gainesville, Florida Metropolitan Statistical Area, which is home to 243,985 people. . Hayes comments, "Our research shows that biomarkers will likely be the key to the detection of brain injury and its severity. Today a simple blood test is used to diagnose heart attacks. In the future, a similar blood test could detect brain injury. This tool would provide invaluable assistance in the management of brain injury patients and the prediction of their clinical course." Brain injury is known as the "silent epidemic" because the injury is difficult to diagnose. Approximately 1.9 million Americans sustain a traumatic brain injury annually. Traumatic brain injury ranks as the leading cause of death and disability in children and young adults. CIMIT, the Center for Integration of Medicine and Innovative Technology, is a non-profit consortium of Boston area teaching hospitals, engineering schools and research laboratories where clinicians, engineers, industry leaders, scientists and the military, work in interdisciplinary teams to generate promising, leading-edge translational technologies for healthcare. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion